%0 Journal Article
%T Ageing in general practice (AGP) trial: a cluster randomised trial to examine the effectiveness of peer education on GP diagnostic assessment and management of dementia
%A Constance D Pond
%A Henry Brodaty
%A Nigel P Stocks
%A Jane Gunn
%A John Marley
%A Peter Disler
%A Parker Magin
%A Nerida Paterson
%A Graeme Horton
%A Susan Goode
%A Bronwen Paine
%A Karen E Mate
%J BMC Family Practice
%D 2012
%I BioMed Central
%R 10.1186/1471-2296-13-12
%X The study is a cluster randomised trial, conducted across three states and five sites. All GPs will complete an audit of their consenting patients aged 75 years or more at three time points - baseline, 12 and 24 months. GPs allocated to the intervention group will receive two educational sessions from a peer GP or nurse, and will administer the GPCOG to consenting patients at baseline and 12 months. The first education session will provide information about dementia and the second will provide individualised feedback on audit results. GPs in the waitlist group will receive the RACGP Guidelines by post following the 12 month auditOutcomes: Primary outcomes are carer and consumer quality of life and depression. Secondary outcomes include: rates of GP identification of dementia compared to a more detailed gold standard assessment conducted in the patient's home; GP identification of differential diagnoses including reversible causes of cognitive impairment; and GP referral to specialists, Alzheimers' Australia and support services. A "case finding" and a "screening" group will be compared and the psychometrics of the GPCOG will be examined.Sample size: Approximately 2,000 subjects aged 75 years and over will be recruited through approximately 160 GPs, to yield approximately 200 subjects with dementia (reducing to 168 by 24 months).The trial outlined in this paper has been peer reviewed and supported by the Australian National Health and Medical Research Council. At the time of submission of this paper 2,034 subjects have been recruited and the intervention delivered to 114 GPs.Australia and New Zealand Clinical Trials Register (ANZCTR): ACTRN12607000117415.Dementia is an increasingly common condition largely due to increasing longevity of the population in Australia, and other countries. Approximately 1 in 5 Australians over the age of 80 have some form of dementia [1]. By 2050 the number of adults 65 to 84 years with dementia is expected to double and the number of pe
%U http://www.biomedcentral.com/1471-2296/13/12